ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Social Media
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
Press
August 6, 2024
05 Nov 2021

Acarix decides on a fully guaranteed rights issue of approximately SEK 79,3 million to expand on the US market

Press release (MAR) Malmö, Sweden, November 5, 2021 Acarix decides on a fully guaranteed rights issue of approximately SEK 79,3 milli...
Continue reading
author-avatar acarix
Press
August 6, 2024
05 Nov 2021

Acarix beslutar om en fullt garanterad företrädesemission om cirka 79,3 MSEK för att expandera på USA-marknaden

Pressrelease (MAR) Malmö, 5 november, 2021 Acarix beslutar om en fullt garanterad företrädesemission om cirka 79,3 MSEK för att expan...
Continue reading
author-avatar acarix
Press
August 6, 2024
27 Oct 2021

Acarix granted US CPT reimbursement code for CADScor System

Press release (MAR)Malmö, Sweden, October 27, 2021 Acarix granted US CPT reimbursement code for CADScor System The editorial panel of...
Continue reading
author-avatar acarix
Press
August 6, 2024
19 Aug 2021

Acarix AB (publ) publishes Interim Report, January – June 2021

Press release Malmö, August 19, 2021 Acarix AB (publ) publishes Interim Report, January – June 2021 Continued positive trend with f...
Continue reading
author-avatar acarix
Press
August 6, 2024
19 Aug 2021

Acarix AB (publ) publicerar delårsrapport, januari – juni 2021

Press release Malmö, 19 augusti, 2021 Acarix AB (publ) publicerar delårsrapport, januari – juni 2021 Fortsatt positiv trend med foku...
Continue reading
author-avatar acarix
Press
August 6, 2024
11 May 2021

Acarix AB (publ) publicerar delårsrapport, januari – mars 2021

Press release Malmö, 11 maj, 2021 Acarix AB (publ) publicerar delårsrapport, januari - mars 2021 Förberedda att möta ett spännand...
Continue reading
author-avatar acarix
Press
August 6, 2024
11 May 2021

Acarix AB (publ) publishes Interim Report, January – March 2021

Press release Malmö, May 11, 2021 Acarix AB (publ) publishes Interim Report, January – March 2021 Prepared for an exciting 2021 ...
Continue reading
author-avatar acarix
Press
August 6, 2024
20 Apr 2021

Acarix publishes the annual report for 2020

         Press releaseMalmö, Sweden, April 20, 2021 Acarix publishes the annual report for 2020 Today, Tuesday April 20, Acarix is p...
Continue reading
author-avatar acarix
Press
August 6, 2024
20 Apr 2021

Acarix publicerar årsredovisningen för 2020

PressmeddelandeMalmö, 20 april 2021 Acarix publicerar årsredovisningen för 2020 Idag, tisdagen den 20 april, publicerar Acarix sin år...
Continue reading
author-avatar acarix
Press
August 6, 2024
18 Feb 2021

Acarix AB (publ) publicerar Bokslutskommuniké 2020

Press release (MAR) Malmö, 18 februari, 2021 Acarix AB (publ) publicerar Bokslutskommuniké 2020 Ett starkt avslut på ett händelserik...
Continue reading
author-avatar acarix
Press
August 6, 2024
18 Feb 2021

A strong ending of an eventful year

Press release (MAR) Malmö, February 18, 2021 Acarix AB (publ) publishes Year-End Report 2020 A strong ending of an eventful year Th...
Continue reading
author-avatar acarix
Press
August 6, 2024
26 Nov 2020

FDA identifies exclusive code for the CADScor®

Press release (MAR)Malmö, Sweden, November 26, 2020 FDA identifies exclusive code for the CADScor® After yesterday’s announcement and...
Continue reading
  • «
  • ‹
  • 10
  • 11
  • 12
  • 13
  • 14
  • ›
  • »
Acarix AB
Jungmansgatan 12
211 19 Malmö
SE
[email protected]

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • News
  • Press
  • Events
  • Cookie policy
  • Full Disclaimer
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Full Disclaimer
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2023. All rights reserved V5

  • Products
    • Background
      • What is Coronary Artery Disease
      • Diagnosing CAD
    • About the product
      • The Cadscor System
      • How Does it Work
  • Resources
    • Testimonial
      • HCP Stories
      • Patients Stories
    • References
      • Clinical Studies
      • Downloads (US)
      • Downloads (EU)
    • Support
      • Training
      • Faq
      • Reimbursement
    • Physician Locator
      • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
      • About Acarix
      • Leadership
      • Join The Team
    • Get in touch
      • Contact Us
      • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.